NCT01691144

Brief Summary

Follow-up of cancer patients accounts for a substantial part of outpatient activity, and alternative models of care are developing. In some countries, low-risk follow-up is already done in primary care, mainly in breast, and colorectal cancer. In this study the investigators will explore gynecological cancer patients about their expectations regarding their future follow-up plan. Further, the investigators will ask about the experience and satisfaction among patients who have already attended a follow-up programme for 2-3 years. In addition, the investigators will especially focus on the cooperation aspect between primary and secondary care. The investigators hypothesize that follow-up of selected gynecological cancer patients can be done by general practitioners.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
239

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2012

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 15, 2012

Completed
17 days until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 24, 2012

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

May 12, 2016

Status Verified

May 1, 2016

Enrollment Period

3.2 years

First QC Date

August 15, 2012

Last Update Submit

May 11, 2016

Conditions

Keywords

cancergynecologicalexpectationssatisfactioncooperation

Outcome Measures

Primary Outcomes (1)

  • Patient expectation questionnaire

    The patients will be asked to fill in a quesionnaire regarding their expectations on follow-up care

    within the first 30 days after primary treatment

Secondary Outcomes (1)

  • Patient satisfaction questionnaire

    3 years after treatment

Study Arms (2)

recently treated patients

2-3 years after treatment

Eligibility Criteria

Age19 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Newly treated gynecological cancer patients and patients treated 2-3 years ago

You may qualify if:

  • \> 18 years
  • histologically or cytologically proven cancer

You may not qualify if:

  • Unability to fill out questionnaires (due to language or cognitive barriers)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sorlandet Hospital Kristiansand

Kristiansand, 4621, Norway

Location

St. Olavs Hospital

Trondheim, 7030, Norway

Location

Related Publications (2)

  • Vistad I, Moy BW, Salvesen HB, Liavaag AH. Follow-up routines in gynecological cancer - time for a change? Acta Obstet Gynecol Scand. 2011 Jul;90(7):707-18. doi: 10.1111/j.1600-0412.2011.01123.x. Epub 2011 Apr 15.

    PMID: 21382018BACKGROUND
  • Vistad I, Cvancarova M, Salvesen HB. Follow-up of gynecological cancer patients after treatment - the views of European experts in gynecologic oncology. Acta Obstet Gynecol Scand. 2012 Nov;91(11):1286-92. doi: 10.1111/j.1600-0412.2012.01523.x. Epub 2012 Sep 18.

    PMID: 22880840BACKGROUND

MeSH Terms

Conditions

Endometrial NeoplasmsOvarian NeoplasmsUterine Cervical NeoplasmsNeoplasmsPersonal Satisfaction

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesEndocrine Gland NeoplasmsOvarian DiseasesAdnexal DiseasesEndocrine System DiseasesGonadal DisordersUterine Cervical DiseasesBehavior

Study Officials

  • Mette Brekke, PhD

    University of Oslo

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

August 15, 2012

First Posted

September 24, 2012

Study Start

September 1, 2012

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

May 12, 2016

Record last verified: 2016-05

Locations